Clinical Trial

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To observe the effect of stem cell infusion on the development of acute graft- versus-host disease (aGVHD) in patients with malignant hematologic diseases after single-unit unrelated cord blood transplantation (sUCBT).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-23; most recent amendment 2025-12-17.
Status change: Not Yet Recruiting → Recruiting 2025-07-02
Trial Details
NCT Number NCT07047456
Lead Sponsor Anhui Provincial Hospital
Conditions Acute Graft Versus Host Disease
Enrollment 134 participants
Start Date 2025-07-11
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-23